STOCK TITAN

Ginkgo Bioworks Holdings Inc - DNA STOCK NEWS

Welcome to our dedicated page for Ginkgo Bioworks Holdings news (Ticker: DNA), a resource for investors and traders seeking the latest updates and insights on Ginkgo Bioworks Holdings stock.

Ginkgo Bioworks Holdings Inc (NYSE: DNA) operates at the forefront of synthetic biology, combining cell programming expertise with biosecurity solutions for industries ranging from pharmaceuticals to agriculture. This news hub provides investors and industry professionals with essential updates on the company's strategic initiatives and technological advancements.

Access real-time announcements including earnings reports, R&D breakthroughs, and strategic partnerships that demonstrate Ginkgo's leadership in biological engineering. The platform serves as a comprehensive resource for tracking developments in their core Cell Engineering services and Biosecurity programs.

Discover updates on Ginkgo's AI-driven innovations, government contracts, and cross-industry collaborations that shape the future of synthetic biology. Content is curated to help stakeholders understand how biological engineering advancements translate to commercial opportunities.

Bookmark this page for streamlined access to verified financial disclosures, operational milestones, and analysis of emerging trends in cell programming technology. Regular updates ensure you stay informed about developments impacting DNA's market position and sector leadership.

Rhea-AI Summary
Synplogen Co. (SYN) and Ginkgo Bioworks (NYSE: DNA) have entered into a non-binding MOU to accelerate the global development of DNA manufacturing and gene therapy platform services in Japan. Synplogen will support and introduce Ginkgo's gene therapy services within the Japanese biotechnology and pharmaceutical ecosystem. Ginkgo will explore global business collaboration opportunities for DNA manufacturing, while Synplogen plans to collaborate by offering business development and marketing support to connect Ginkgo's services with Japanese biotechnology and pharmaceutical companies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.31%
Tags
none
-
Rhea-AI Summary
Vivici BV (DNA) partners with Ginkgo Bioworks to advance sustainable and nutritious dairy protein production through precision fermentation. The collaboration aims to leverage Ginkgo's Protein Production Services and AI platform to deliver optimized strains for dairy protein production, supporting Vivici's mission to provide planet-friendly nutrition to consumers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.79%
Tags
none
-
Rhea-AI Summary
Foremost Farms USA (NYSE: DNA) and Ginkgo Bioworks Partner to Upcycle Dairy Co-products into Value-Added Materials, Reducing Carbon Footprint and Lowering Manufacturing Costs
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.44%
Tags
none
Rhea-AI Summary
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) added 21 new Cell Programs to the Foundry platform in Q3 2023 and entered into a strategic cloud and AI partnership with Google Cloud. They also signed a new multi-target RNA drug discovery collaboration with Pfizer, with potential payments of up to $331 million. Ginkgo ended Q3 2023 with over $1.0 billion in cash and cash equivalents, maintaining a multi-year runway as they continue to drive towards profitability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.44%
Tags
-
Rhea-AI Summary
Ginkgo Bioworks (NYSE: DNA) will host a presentation and Q&A session on November 8, 2023, to review business performance for Q3 2023. The session will begin at 5:30 p.m. ET and will be available on Ginkgo's investor relations website. Questions can be submitted via Twitter or email.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
-
Rhea-AI Summary
Ginkgo Bioworks partners with Penn State University to integrate biosurveillance capabilities into research of 58 wildlife species for SARS-CoV-2. The initiative aims to monitor potential spillover to humans and prevent the spread of new variants. The research will provide data for informed decision-making by public health officials.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.37%
Tags
partnership
Rhea-AI Summary
Ginkgo Bioworks and the Government of Serbia have entered into a Memorandum of Understanding to collaborate on Serbia's bioeconomy vision. They will establish a Startup Accelerator leveraging Ginkgo's platform to support Serbian companies building with biology. Serbia's BIO4 campus initiative aims to make Serbia a bioeconomy hub in Europe and has already signed MoUs with various companies. Ginkgo will offer flexible services to companies at BIO4 and explore partnerships to develop biomonitoring capabilities in Serbia.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.64%
Tags
none
-
Rhea-AI Summary
Persephone Biosciences and Ginkgo Bioworks complete their collaboration on a Bacteroides engineering toolkit
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.57%
Tags
none
-
Rhea-AI Summary
Ginkgo Bioworks and Zenfold Sustainable Technologies collaborate to develop sustainable manufacturing technology for veterinary products
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.2%
Tags
none
Rhea-AI Summary
QL AG announces collaboration with Ginkgo Bioworks to develop dairy proteins
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.43%
Tags
partnership
Ginkgo Bioworks Holdings Inc

NYSE:DNA

DNA Rankings

DNA Stock Data

455.56M
54.26M
6.6%
79.85%
15.62%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
BOSTON